FilingReader Intelligence
North China Pharmaceutical expects substantial profit growth
July 10, 2025 at 08:49 AM UTC•By FilingReader AI
North China Pharmaceutical projects a considerable increase in its net profit attributable to shareholders for the first half of 2025. The company estimates a net profit of approximately CNY 12,350,000, representing a 72% increase compared to the same period last year.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:600812•Shanghai Stock Exchange
News Alerts
Get instant email alerts when North China Pharmaceutical publishes news
Free account required • Unsubscribe anytime